Breaking News
October 16, 2018 - MDI Biological Laboratory receives $1.2 million SEPA grant to promote data literacy
October 16, 2018 - Vast majority of dementia cases may arise from spontaneous genetic errors
October 16, 2018 - New project aims to deliver fast, effective treatment for autoimmune rheumatic diseases
October 16, 2018 - Study identifies molecular switch that controls fate of milk-producing breast cells
October 16, 2018 - Research shows diet has little influence on precursor to gout
October 16, 2018 - “Without Dr. Shumway doing his miracle work, three generations would not be here”: A Stanford heart transplant patient’s story
October 16, 2018 - Researchers demonstrate integrated technique to control production of cell therapeutics
October 16, 2018 - Breast tomosynthesis detects 34% more tumors than traditional mammography
October 16, 2018 - Rhode Island Hospital, Brown receive $800,000 grant to keep up fight against opioid epidemic
October 16, 2018 - UVA partners with health systems in AVIA network’s Medicaid Transformation Project
October 16, 2018 - Trevena Announces Oliceridine FDA Advisory Committee Meeting Outcome
October 16, 2018 - Study reveals early warning signs of heart problems in patients with newly diagnosed lupus
October 16, 2018 - Connecting the dots of Alzheimer’s disease
October 16, 2018 - New publication offers evidence-based content for global breast imaging medical community
October 16, 2018 - ‘EinsteinVision’ that improves hand-eye coordination of surgeons introduced at Harefield Hospital
October 16, 2018 - WRAIR clinical study evaluates safety and immunogenicity of Marburg vaccine
October 16, 2018 - Ketamine can be considered as alternative to opioids for short-term pain control in ED
October 16, 2018 - Endurance exercise training beneficially alters gut microbiota composition
October 15, 2018 - FDA Approves Yutiq (fluocinolone acetonide intravitreal implant) for Chronic Non-Infectious Posterior Segment Uveitis
October 15, 2018 - Birthing Options for Full-Term Pregnancy
October 15, 2018 - Stressed, toxic, zombie cells seen for first time in Alzheimer’s
October 15, 2018 - Concussion researchers study head motion in high school football hits | News Center
October 15, 2018 - Neuropsychiatric symptoms related to earliest stages of Alzheimer’s brain pathology
October 15, 2018 - Neck collar device may help protect the brain of female high school soccer players
October 15, 2018 - Research reveals how the inner ear processes speech
October 15, 2018 - Many parents still skeptical about safety and effectiveness of flu shot, survey finds
October 15, 2018 - Payer Policies May Discourage Non-Pharma Tx for Low Back Pain
October 15, 2018 - Exercise may delay cognitive decline in people with rare Alzheimer’s disease
October 15, 2018 - Researchers modify CRISPR to reorganize genome | News Center
October 15, 2018 - Innovative brain tumor operation set to tailor to patients’ needs
October 15, 2018 - Findings offer new insight into early changes that occur during AD pathology
October 15, 2018 - Neurons regulating reproductive hormone release have different activity in epileptic mice
October 15, 2018 - More parents are concerned about taking babies swimming in public pools
October 15, 2018 - Health Tip: Know the Risk Factors for Lower Back Pain
October 15, 2018 - Study shows cigarillo flavors enhanced by high-intensity sweeteners
October 15, 2018 - Study traces hospital-acquired bloodstream infections to patients’ own bodies | News Center
October 15, 2018 - Abnormal vision in childhood can affect development of brain areas responsible for attention
October 15, 2018 - Study highlights need for increased support for alcohol-related liver disease patients
October 15, 2018 - Color-changing contact lens could help doctors to monitor eye disease medications
October 15, 2018 - Tobacco heating products cause less staining to teeth than conventional cigarettes
October 15, 2018 - Young adults who are obese can expect to lose up to 10 years in life expectancy
October 15, 2018 - Scientists uncover how proteins meet on the cell membrane
October 15, 2018 - Affordable housing with supportive social services for senior citizens can reduce hospital use
October 15, 2018 - Schiller Easy Pulse Saves Lives
October 15, 2018 - The latest ECG device from Schiller
October 15, 2018 - Following a Tissue Sample
October 15, 2018 - Prisoners need drug and alcohol treatments but AA programs aren’t the answer
October 15, 2018 - Andrea Califano and Jordan Orange Elected to National Academy of Medicine
October 15, 2018 - The impending risk of African Swine Fever Virus
October 15, 2018 - Breastfeeding reduces the number of antibiotic-resistant bacteria in infant gut
October 15, 2018 - Researchers develop comprehensive molecular atlas of postnatal mouse heart development
October 15, 2018 - ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting
October 15, 2018 - Engineering teratoma-derived fibroblasts to enhance osteogenesis
October 15, 2018 - Lab study shows effectiveness of potential therapy for treatment-resistant hypothyroidism
October 15, 2018 - JCU study firms up association between diet and depression
October 15, 2018 - Researchers to study the use of CRISPR on human liver on-a-chip platform
October 15, 2018 - Sub-concussive impacts not associated with decline in neurocognitive function
October 15, 2018 - Researchers find potential treatment to halt premature labor and birth
October 15, 2018 - As U.S. suicides rates rise, Hispanics show relative immunity
October 15, 2018 - FDA Issues a Complete Response Letter to Acacia Pharma for Barhemsys
October 15, 2018 - Photoactive bacteria bait may help in fight against MRSA infections
October 15, 2018 - Increasing vigorous exercise reduces risk factors of type 2 diabetes, cardiovascular disease in children
October 15, 2018 - First-of-its-kind study to test a personalized vaccine in cancer patient
October 15, 2018 - Extension trial assesses benefit of switching from flash monitoring to RT-CGM for hypoglycemia
October 15, 2018 - Half of parents say young children are afraid of doctor’s visits
October 15, 2018 - Study shows how fingerprint-based drug screening works on the living and deceased
October 15, 2018 - Study reveals potential to monitor progression of Alzheimer’s disease by measuring brain antioxidant levels
October 15, 2018 - FDA Approves Xarelto to Reduce the Risk of Major Cardiovascular Events in Patients with Chronic Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD)
October 15, 2018 - Promising new therapeutic approach against Ebola virus identified
October 15, 2018 - Study unravels how cancer stem cells use normal genes in abnormal ways
October 15, 2018 - Healthcare systems fail to deliver at affordable prices finds report
October 15, 2018 - Intensive BP Therapy in Diabetes May Lower Risk for CV Events
October 15, 2018 - Muscle relaxants increase risk of respiratory complications
October 15, 2018 - Female birds become more promiscuous after hatchings fail in the first breeding attempt
October 15, 2018 - Humans occupied Madagascar thousands of years later than previously thought
October 15, 2018 - Is Kidney Dialysis Always Needed When Septic Shock Strikes?
October 15, 2018 - Study shows invasive lung cancer surgery can lead to long-term opioid use
October 15, 2018 - Sugar, a “sweet” tool to understand brain injuries
October 14, 2018 - King’s commemorates activities and research on World Arthritis Day
October 14, 2018 - Humana and VFW NY team up on Stop 22 initiative to increase awareness of veterans committing suicide
FDA warning against Kratom strengthened

FDA warning against Kratom strengthened

image_pdfDownload PDFimage_print

Dr Ananya Mandal, MD

The U.S. Food and Drug Administration (FDA) has amped up its warnings against popular herbal drug kratom. The new warning mentions the deadly risks associated with kratom including a case of a teenager who hanged himself under influence.

Mitragyna speciosa,mitragyna speciosa korth (kratom) a drug from plant to a category 5 in Thailand. Image Credit: sarintra chimphoolsuk / Shutterstock

Mitragyna speciosa,mitragyna speciosa korth (kratom) a drug from plant to a category 5 in Thailand. Image Credit: sarintra chimphoolsuk / Shutterstock

The new warning statement issued by the FDA states that the effects of this herbal concoction is yet to be understood clearly. The effects of kratom in the cases of fatalities are being investigated to see the extent of damage this drug can cause.

FDA Commissioner Scott Gottlieb, in a press release this Tuesday (6th of February 2018), said that this was a reinforcement of an earlier health advisory that was released last November. The earlier advisory stated that there was “clear data on the increasing harms associated” with kratom. This was because of the 36 deaths associated with kratom at the time. In this new statement Gottlieb said that the present death count is up to 44 deaths. He explained that the FDA has classified the substance as an opioid and this would require further “scientific analysis”. He said, “This new data adds to our body of substantial scientific evidence supporting our concerns about the safety and abuse potential of kratom… As the scientific data and adverse event reports have clearly revealed, compounds in kratom make it so it isn’t just a plant — it’s an opioid.”

Kratom is derived from a plant that grows in South east Asia. It is related to coffee and the leaves are used to make the drug. It is available at online portals and websites in the form of powder packaged within capsules or as tea. Kratom can act as a mood enhancer or as a sedative. Its effects as a stimulant or a sedative depend on the variety of the plant or on the dosage taken. It has been claimed to treat long term pain, depression and anxiety disorders effectively. It has also been used by heroin abusers who wish to step down from their addiction. It is being touted as a “non-opioid” alternative to traditional opioids. However, being an unregulated drug available for use and made by multiple manufacturers in a non-standardized manner, the quality of the drug is not assured as it its dosage, composition and packaging. This may lead to adulteration and overdosage on self-medication, says the FDA. The FDA warns that as of now the claims in favour of kratom have not been verified scientifically and the potential harms are known.

Gottlieb added in his statement that kraton has a potential for “abuse, addiction, and serious health consequences; including death.” The 36 death reports earlier, he said were reported in academic research, adverse event reports from Accident and Emergency Departments and from the reports of the Medical Examiners. Reports of the eight new cases are also to be rel;eased shortly, he said. These victims were all on multiple substances at the time of death he said. These were all illicit and harmful drugs. The teenager who hanged himself for example tested positive for kratom, alcohol and several other prescription drugs. Another person who feel out of a window under influence showed high blood levels of mitragynine. This is the main psychoactive substance that is present in kratom. Another middle aged man who died of overdose, was found to have opioids, benzodiazepines as well as kratom in his blood. Only one of the deaths was due to kratom alone states the FDA. Gottlieb said that this case was being investigated and also that it was not an absolute proof that kratom could be causing these deaths alone.

“Many of the cases received could not be fully assessed because of limited information provided,” Gottleib said, adding, “a few cases raise concern that kratom is being used in combination with other drugs.” “Cases of mixing kratom, other opioids, and other types of medication is extremely troubling because the activity of kratom at opioid receptors indicates there may be similar risks of combining kratom with certain drugs, just as there are with FDA-approved opioids,” Gottlieb said.

After this statement, kratom could be facing a ban under federal law say experts. FDA sent the Drug Enforcement Administration (DEA) an “8 factor analysis” to place the drug under a schedule and reduce its free availability and increase user awareness.

Tagged with:

About author

Related Articles